Skip to content

Hyland’s names VP of sales

Les Hamilton has joined homeopathic medicine manufacturer Hyland’s Inc. as vice president of sales. Hyland’s said Monday that Hamilton comes to the company from The Emerson Group, where he served as field sales manager for seven years.

Table of Contents

LOS ANGELES — Les Hamilton has joined homeopathic medicine manufacturer Hyland’s Inc. as vice president of sales.

Hyland’s said Monday that Hamilton comes to the company from The Emerson Group, where he served as field sales manager for seven years.

As vice president of sales, Hamilton will be responsible for guiding Hyland’s sales organization and developing and implementing sales strategy.

"I have known Les for many years, and I am confident that he brings to Hyland’s the right mix of experience, accomplishment and culture that aligns perfectly with our core values," Dale Nepsa, president of Hyland’s, said in a statement.

"Les will be working closely with our outstanding sales teams in both natural foods and food, drug and mass merchandisers," Nepsa added. "He will be a valued member of our senior management team, providing a comprehensive sales perspective to the operations of our company.”

Hamilton has more than 15 years of experience in the consumer products industry and sales and marketing of over-the-counter drugs. While at The Emerson Group, he managed accounts of all sizes, most recently managing the Target Corp. business for all of Emerson’s OTC products. His prior experience includes almost 10 years at Target, where he held various positions, including category manager for a number of pharmacy categories and all OTC private-label items.

"I feel honored to be joining such a great company with great people," commented Hamilton. "I am excited to be leading a team that offers a wide variety of homeopathic medicines as natural solutions to feeling better. I look forward to helping grow our business."

Comments

Latest

FMI: Private brands take hold

FMI: Private brands take hold

Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”